Brief: Amicus Therapeutics Q2 Revenue USD 94.5 Million Vs. IBES Estimate USD 89.9 Million
08/08/2023 12:00
Aug 08 (Reuters) - Amicus Therapeutics Q2 net income USD -43.2 million. * outlook FY revenue growth 14-18%
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates